Delivery Order SPE2DB20D3103-SPE2DB24FP8U3

Award Date 8/13/24
Potential Completion Date 8/14/24
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency, with Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OLUMIANT 4 MG TABLET 30S. The Firm Fixed Price contract has a ceiling value of $14,798.55 and a period of performance through June 6, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,397.99, is for the delivery of OLUMIANT 2 MG TABLET 30S, a medication used in the treatment of certain medical conditions. The contract has a firm fixed price pricing type and an ultimate completion date of March 19, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,476.62, is for the delivery of OLUMIANT 4 MG TABLET 30S, a medication used to treat certain medical conditions. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the supply of OLUMIANT 2 MG TABLET 30S, with a ceiling value of $7,731.75 and a performance period ending on May 22, 2025. The contract is a firm fixed price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a Delivery Order valued at $4,043.48 issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product, with a completion date of May 30, 2025. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product, with a potential value of $1,962.58 and a completion date of January 26, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, and it is part...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $1,023.41 and an ultimate completion date of August 29, 2024. The contract is a Firm Fixed Price type and has no set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office Division, is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award is a Delivery Order with a Firm Fixed Price pricing type, valued at $19,019.85, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of OLUMIANT 2 MG TABLET 30S, with a period of performance through June 16, 2025. The contract is not set aside and was awarded through open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, valued at $82,443.07 for the delivery of Olumiant 4 mg tablets. The contract has a period of performance through September 25, 2024 and is structured as a firm-fixed-price arrangement. This delivery order is placed against an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a ceiling...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC is valued at $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific contract award is for the delivery of 4567156621 - OLUMIANT 4 MG...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP8U3
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of OLUMIANT 4 MG TABLET 30S, a prescription medication. The contract has a ceiling value of $17,522.37 and is set to expire on August 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999, which covers the delivery of a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation. As one of the largest pharmaceutical distributors in the United States, Amerisourcebergen leverages its extensive supply chain network to provide essential medical commodities to various government agencies and healthcare programs.

Generated 11/12/24, 9:01 AM